This site uses cookies to provide you with a better browsing experience. Find out more about our cookie policy and how to change the setting on your browser.
  +32 2 772 8900


Please wait...

Startup In2Care part of $10.2 million study to prevent malaria

In2Care is a startup from Stichting Startlife , our newly accredited EU|BIC member in Wageningen, Netherlands.
The startup recently received a 10.2 million dollar grant to participate for five years with other partners in the US, UK and Africa in a study funded by a grant from the Bill & Melinda Gates Foundation to test a new method for preventing the transmission of malaria.
The method involves limiting mosquito access to houses by screening windows and installing “eave tubes” that contain a unique type of insecticide-laced netting developed by In2Care that kills the insects as they attempt to enter.

In2Care was founded by two PhDs, Remco Suer and Marit Fahrenorst, from Wageningen University who were working on the biological pest control of malaria transmitted by mosquitoes. They integrated the Wageningen incubator Stichting Startlife in 2012 where they received full support for coaching, business development and access to privileged service providers and advisors from the Startlife network on finance, legal and validation issues. In addition, In 2014 In2care applied for one of the early stage loans delivered by Startlife and for workspace in Kadans Science incubator which is partner of Startlife.

Associated member: StartHub Wageningen
Published on 22-01-2016 00:00 by Nathalie Marchand. 3449 page views

Back to News list
EBN Newsletter
Our Publications
Our Network
Sector Specialisation

Vertical Sectors

Cross-cutting Themes


 Recent Tweets